Drug Shortage Report for TRISENOX
| Report ID | 15753 |
| Drug Identification Number | 02407833 |
| Brand name | TRISENOX |
| Common or Proper name | Arsenic Trioxide for Injection |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ARSENIC TRIOXIDE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 mg/10mL ampoule |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-09-08 |
| Actual start date | 2017-09-08 |
| Estimated end date | 2018-07-20 |
| Actual end date | 2018-07-24 |
| Shortage status | Resolved |
| Updated date | 2018-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2017-07-27 | French | Compare |
| v14 | 2017-07-26 | French | Compare |
| v13 | 2017-07-26 | English | Compare |
| v12 | 2017-07-26 | French | Compare |
| v11 | 2017-07-26 | English | Compare |
| v10 | 2017-07-21 | French | Compare |
| v9 | 2017-07-21 | French | Compare |
| v8 | 2017-07-21 | French | Compare |
| v7 | 2017-07-21 | English | Compare |
| v6 | 2017-07-19 | French | Compare |
| v5 | 2017-07-19 | English | Compare |
| v4 | 2017-07-19 | English | Compare |
| v3 | 2017-07-14 | English | Compare |
| v2 | 2017-07-14 | French | Compare |
| v1 | 2017-07-14 | English | Compare |